Relationships between serum uric acid and lipids in healthy subjects

Preventive Medicine

Volumn 25, Issue 5, 1996, Pages 611-616

  Russo, Carla ^a   Olivieri, Oliviero ^a   Girelli, Domenico ^a   Guarini, Patrizia ^a   Corrocher, Roberto ^a,b  

^a UNIVERSITY OF VERONA   (Italy)

^b POLICLINICO BORGO ROMA   (Italy)

Author keywords

dietary fatty acids; lipids; triglycerides; uric acid; 6 PUFA

Indexed keywords

FATTY ACID; LIPID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; DIETARY INTAKE; DISEASE ASSOCIATION; ERYTHROCYTE MEMBRANE; FAT INTAKE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERURICEMIA; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL;

EID: 0030248466     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.1996.0096     Document Type: Article

References (39)

1. 1. Gertler MM, Garn SM, Levine SA. Serum uric acid in relation to age and physique in health and coronary heart disease. Ann Intern Med 1951;34:1421-31.
2. 2. Collantes EE, Pineda PM, Anon BJ, Sanchez JP. Hyperuricaemia-hyperlipidemia association in the absence of obesity and alcohol abuse. Clin Rheumatol 1990;9:28-31.
3. 3. Tuomilehto J, Zimmet P, Wolfe E, Taylor R, Ram P, King H. Plasma uric acid level and its association with diabetes mellitus and some biological parameters in a biracial population of Fiji. Am J Epidemiol 1985;127:321-36.
4. 4. Breckenridge A. Hypertension and hyperuricaemia. Lancet 1966;1:15-8.
5. 5. Kahn HA, Medalie JH, Neufeld HN, Riss E, Gouldbourt U. The incidence of hypertension and associated factors: the Israel ischemic heart disease study. Am Heart J 1972;84:171-82.
6. 6. Selby JV, Friedman GD, Queennsberry CP Jr. Precursor of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol and other serum chemistries. Am J Epidemiol 1990;131:1017-27.
7. 7. Takunen H, Reunanen A. Hyperuricaemia and other cardiovascular risk factors. In: Muller MM, Kaiser E, Seegmiller JE, editors. Purine metabolism in man.II. Physiology, pharmacology and clinical aspects. New York: Plenum, 1977:238-41.
8. 8. Persky VW, Dyer AE, Idris-Soven E, Stamler J, Shekelle RB, Schoenberger JA, et al. Uric acid: a risk factor for coronary heart disease? Circulation 1979;59:969-77.
9. 9. Yano K, Rhoads GG, Kagan A. Epidemiology of serum urate levels among 8000 Japanese-American men in Hawaii. J Chron Dis 1977;30:171-84.
10. 10. Welborn TA, Cumpstone GN, Cullen KJ, Curnow DH, McCall MG, Stenhouse NS. The prevalence of coronary heart disease and associated factors in an Australian rural community. Am J Epidemiol 1969;89:521-36.
11. 11. Kagan A, Gordon T, Rhoads G, Schiffman JC. Some factors related to coronary heart disease incidence in Honolulu Japanese men: the Honolulu Heart Study. Int J Epidemiol 1975;4:271-9.
12. 12. Brand FN, McGee DL, Kannel WB, Stokes J III, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study. Am J Epidemiol 1985;121:11-8.
13. 13. Goldbourt U, Medalie JH, Herman JB, Neufeld HN. Serum uric acid: correlation with biochemical, anthropometric, clinical and behavioral parameters in 10,000 Israeli men. J Chron Dis 1980;33:435-43.
14. 14. Loenen HMJA, Eshuis H, Lowik MRH, Scheuten EG, Hulshof KFAM, Odink J, et al. Serum uric acid correlates in elderly men and women with special reference to body composition and dietary intake (Dutch nutrition surveillance system). J Clin Epidemiol 1990;43:1297-303.
15. 15. Angelico F, Arca M, Calvieri A, Cantafora A, Guccione P, Monini P, et al. Plasma and erythrocyte fatty acids: a methodology for evaluation of hypocholesterolemic dietary interventions. Prev Med 1983;12:124-7.
16. 16. Dougherty RM, Galli C, Ferro-Luzzi A, Iacono JM. Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: a study of normal subjects from Italy, Finland and the USA. Am J Clin Nutr 1987;45:443-5.
17. 17. Glatz JFC, Soffers AEMF, Katan MB. Fatty acid composition of serum cholesteryl esters and erythrocyte membranes as indicators of linoleic acid intake in man. Am J Clin Nutr 1989;49:269-76.
18. 18. Olivieri O, Stanzial AM, Girelli D, Trevisan MT, Guarini P, Terzi M, et al. Selenium status, fatty acids, vitamins A and E and aging: the Nove study. Am J Clin Nutr 1994;60:510-7.
19. 19. Girelli D, Azzini M, Olivieri O, Guarini P, Trevisan MT, Lupo A, et al. Red blood cells and platelet membrane fatty acids in non-dialyzed and dialyzed uremics. Clin Chim Acta 1992;211: 155-66.
20. 20. Horrobin DF. Omega-6 and omega-3 essential fatty acids in atherosclerosis. Semin Thromb Hemostasis 1993;19:129-37.
21. 21. Nørdoy A, Goodnight SH. Dietary lipids and thrombosis: relationships to atherosclerosis. Arteriosclerosis 1990;10:149-63.
22. 22. Wilkinson L. Systat: Statistics, version 5.2 edition. Evanston (IL): Systat, Inc., 1992:116.
23. 23. Bulpitt CJ. Serum uric acid in hypertensive patients. Br Heart J 1975;37:1210-15.
24. 24. Nicholls A, Scott JT. Effects of weight loss on plasma and urinary levels of uric acid. Lancet 1972;2:1223-4.
25. 25. Okada M, Takeshita M, Ueda K, Omae T, Hirota Y. Factors influencing the serum uric acid level: a study based on a population survey in Hisayama town, Kyushu, Japan. J Chron Dis 1980;33:607-12.
26. 26. Ramsay LE. Hyperuricaemia in hypertension: role of alcohol. Br Med J 1979;1:653-4.
27. 27. Faller J, Fox I. Ethanol-induced hyperuricemia: evidence for increased urate production by activation of adenine nucleotide turnover. N Engl J Med 1982;307:1598-602.
28. 28. Wyngaarden JB, Kelley WN. Gout and hyperuricemia. New York: Grune & Stratton, 1976:21-37.
29. 29. Matsubara K, Matsuzawa Y, Jiao S, Takama T, Kubo M, Tarui S, et al. Relationship between hypertriglyceridemia and uric acid production in primary gout. Metabolism 1989;38:698-701.
30. 30. Vuorinen-Markkola H, Yki-Jarvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994;78:25-9.
31. 31. Bartolin R, Bouvenot G, Delboy C, Soula G, Levy S. L'uricèmie et la maladie coronarienne. Arch Mal Coeur 1981;74:1307-13.
32. 32. Zalokar J, Lellouch J, Claude JR, Kuntz D. Epidemiology of serum uric acid and gout in Frenchmen. J Chron Dis 1974;27:59-75.
33. 33. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
34. 34. Ulbricht TLV, Southgate DAT. Coronary heat disease: seven dietary factors. Lancet 1991;338:985-92.
35. 35. Mikkelsen WM, Dodge HJ, Valkenburg H. The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia. Am J Med 1965;39:242-51.
36. 36. Nichols A, Suaith ML, Scott JT. Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br Med J 1973;1:449-51.
37. 37. Corrocher R, Steinmayr M, Ruzzenente O, Brugnara C, Bertinato L, Mazzi M, et al. Elevation of red cell sodium-lithium countertransport in hyperlipidemias. Life Sci 1985;36:649-55.
38. 38. Doria A, Fioretto P, Avogaro A, Canoro A, Morocutti A, Trevisan R, et al. Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension. Am J Physiol 1991;E684-91.
39. 39. Corrocher R, Ferrari S, Bassi A, Guarini P, Bertinato L, Olivieri O, et al. Membrane polyunsaturated fatty acids and lithium-sodium countertransport in human erythrocytes. Life Sci 1987;41:1171-8.